Portola Pharmaceuticals, Inc.
(NASDAQ : PTLA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.15%27.7514.1%$163.28m
RVMDRevolution Medicines, Inc. -2.04%28.310.0%$120.04m
AMRNAmarin Corp. Plc -0.40%17.621.7%$106.11m
CTLTCatalent, Inc. 1.43%60.452.2%$71.17m
GWPHGW Pharmaceuticals Plc 0.76%127.106.2%$67.15m
JAZZJazz Pharmaceuticals Plc -0.76%140.852.3%$59.43m
AXSMAxsome Therapeutics, Inc. 2.03%90.471.9%$54.45m
ICPTIntercept Pharmaceuticals, Inc. 0.16%94.8416.9%$49.24m
UTHRUnited Therapeutics Corp. 0.19%104.1914.3%$48.27m
HZNPHorizon Therapeutics Plc 0.25%35.936.6%$47.54m
SAGESAGE Therapeutics, Inc. 0.06%68.088.6%$45.35m
PRGOPerrigo Co. Plc -0.36%57.756.8%$44.68m
ZGNXZogenix, Inc. -0.22%32.189.4%$43.34m
MNKMallinckrodt Plc -8.72%4.5020.9%$40.50m
ENDPEndo International Plc -0.81%6.158.8%$39.71m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. It offers Andexxa, and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.